An ad airing Super Bowl Sunday features “America’s deadliest epidemic,” obesity, and what can be done about it with the use of “affordable” compounded weight loss drugs.
Wegovy and Ozempic are the same drug, semaglutide. Wegovy is simply sold at a higher dose and marketed for weight loss instead of diabetes. I was interested in the cardiovascular authorization ...
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth ... “We all we seek to put projections out that we can hit with confidence...within the range of ...
Lilly Chief Financial Officer Lucas Montarce told Reuters last month the drugmaker is trying to balance its demand-generation activities with its ability to supply more patients. The company last year ...
On TikTok, where the 31-year-old mother of three chronicled her weight loss ... Zepbound to help with symptoms of the condition as well as maintaining a healthy weight. Since starting the ...
The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular ... even—to really flesh out [that story] completely.” ...
Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of these drugs.
When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs ... about the drugs. “I think there’s still a lot of unknowns out there,” he said.
Independence Blue Cross, a major insurance company, is no longer covering drugs like Zepbound prescribed solely for weight loss, blaming exorbitant ... "I was pre-diabetic, I was pre-hypertensive.
MORGANTOWN – WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for ...
About 140,400 obese patients in Massachusetts were prescribed medications such as Wegovy and Zepbound in ... As it turns out, her plan excludes payment for weight-loss drugs.
The names at the forefront of weight loss drugs are Eli Lilly, the U.S. manufacturer of Mounjaro and Zepbound; and Novo Nordisk, the Danish maker of Ozempic, Saxenda, and Wegovy. However ...